Siemens Healthineers is a German multinational medical technology company focused on diagnostic and therapeutic imaging, diagnostics, and related healthcare solutions. The company was founded in 2017 and is headquartered in Erlangen, Germany. Its shares are listed on the Frankfurt Stock Exchange under ticker SHL.
The UK's £1.6bn national AI strategy targets healthcare breakthroughs from cancer detection to drug discovery. The AI healthcare market is forecast to reach US$696bn by 2034, a 38.5% CAGR.
Boston Scientific exceeded Q4 2025 guidance with 12.7% organic revenue growth and over $20 billion in annual sales. The company outlined a 2026 outlook of 10-11% organic growth, while shares fell 17.6% after earnings due to supply-chain issues and EP share losses.
The AI-driven precision medicine market is projected to grow from $0.7 billion in 2025 to $9.7 billion by 2035 at a 26.8% CAGR. North America dominates with 62-67% market share, while machine learning accounts for 39% of the market. The market is moderately consolidated with the top five players controlling over 64% share.
Phase III trial of 196 patients shows stereotactic radiation targeting individual tumors significantly improved symptom burden and daily functioning compared with hippocampal-avoidance whole-brain radiation, without compromising survival.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07582744 |
CVFs in SIH: EID vs. PCD CTM |
RECRUITING | NA |
| NCT04931771 |
Fractional Flow Reserve or 3D-Quantitative-Coronary-Angiography Based Vessel-FFR Guided Revascularization |
COMPLETED | NA |
| NCT04772157 |
Safe Emergency Department DIscharGE Rate (SEIGE) |
COMPLETED | |
| NCT04280926 |
Use of High Sensitivity Cardiac Troponin in Ruling Out Emergency Patients with Acute Myocardial Injury and Infarction |
COMPLETED |
